BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18025309)

  • 1. Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor.
    Baumgärtner P; Geiger M; Zieseniss S; Malleier J; Huntington JA; Hochrainer K; Bielek E; Stoeckelhuber M; Lauber K; Scherfeld D; Schwille P; Wäldele K; Beyer K; Engelmann B
    J Cell Biol; 2007 Nov; 179(4):793-804. PubMed ID: 18025309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles.
    Nishioka J; Ning M; Hayashi T; Suzuki K
    J Biol Chem; 1998 May; 273(18):11281-7. PubMed ID: 9556620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A+-helix of protein C inhibitor (PCI) is a cell-penetrating peptide that mediates cell membrane permeation of PCI.
    Yang H; Wahlmüller FC; Sarg B; Furtmüller M; Geiger M
    J Biol Chem; 2015 Jan; 290(5):3081-91. PubMed ID: 25488662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New lipid interaction partners stimulate the inhibition of activated protein C by cell-penetrating protein C inhibitor.
    Wahlmüller FC; Sokolikova B; Rieger D; Geiger M
    Thromb Haemost; 2014 Jan; 111(1):41-52. PubMed ID: 24136361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C inhibitor (PCI) binds to phosphatidylserine exposing cells with implications in the phagocytosis of apoptotic cells and activated platelets.
    Rieger D; Assinger A; Einfinger K; Sokolikova B; Geiger M
    PLoS One; 2014; 9(7):e101794. PubMed ID: 25000564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo.
    Einfinger K; Badrnya S; Furtmüller M; Handschuh D; Lindner H; Geiger M
    PLoS One; 2015; 10(11):e0143137. PubMed ID: 26580551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin.
    Yang L; Manithody C; Walston TD; Cooper ST; Rezaie AR
    J Biol Chem; 2003 Sep; 278(39):37465-70. PubMed ID: 12878585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the H helix in heparin binding to protein C inhibitor.
    Shirk RA; Elisen MG; Meijers JC; Church FC
    J Biol Chem; 1994 Nov; 269(46):28690-5. PubMed ID: 7961820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Extracellular SERPINA5 (Protein C Inhibitor) Penetration Through Cellular Membranes.
    Wahlmüller FC; Yang H; Furtmüller M; Geiger M
    Adv Exp Med Biol; 2017; 966():93-101. PubMed ID: 28639251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetrating SERPINA5 (ProteinC inhibitor, PCI): More questions than answers.
    Yang H; Geiger M
    Semin Cell Dev Biol; 2017 Feb; 62():187-193. PubMed ID: 27989561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular interactions between protein C inhibitor and coagulation proteases.
    Cooper ST; Whinna HC; Jackson TP; Boyd JM; Church FC
    Biochemistry; 1995 Oct; 34(40):12991-7. PubMed ID: 7548057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C inhibitor--a novel antimicrobial agent.
    Malmström E; Mörgelin M; Malmsten M; Johansson L; Norrby-Teglund A; Shannon O; Schmidtchen A; Meijers JC; Herwald H
    PLoS Pathog; 2009 Dec; 5(12):e1000698. PubMed ID: 20019810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity.
    Phillips JE; Cooper ST; Potter EE; Church FC
    J Biol Chem; 1994 Jun; 269(24):16696-700. PubMed ID: 8206990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor.
    Suzuki K
    FEBS J; 2010 May; 277(10):2223-9. PubMed ID: 20402764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of recombinant human protein C inhibitor expressed in Escherichia coli.
    Réhault SM; Zechmeister-Machhart M; Fortenberry YM; Malleier J; Binz NM; Cooper ST; Geiger M; Church FC
    Biochim Biophys Acta; 2005 Apr; 1748(1):57-65. PubMed ID: 15752693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation.
    Huntington JA; Kjellberg M; Stenflo J
    Structure; 2003 Feb; 11(2):205-15. PubMed ID: 12575940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. Evidence for a protein-mediated and ATP-dependent process(es).
    Martin OC; Pagano RE
    J Biol Chem; 1987 Apr; 262(12):5890-8. PubMed ID: 3571240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.